Relationship between N-terminal pro-B-type natriuretic peptide levels and metabolic syndrome

Archives of Medical Science

Volumn 7, Issue 2, 2011, Pages 247-256

  Bao, Yuanyuan ^a   Shang, Xiliang ^a   Zhou, Linuo ^a   Hu, Renming ^a   Li, Yiming ^a   Ding, Wei ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Hyperlipidaemia; Left ventricular mass index; Natriuretic peptide; Risk factors

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANALYSIS OF COVARIANCE; ARTICLE; BLOOD LEVEL; BODY MASS; CHEMOLUMINESCENCE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCHEMILUMINESCENCE; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIPLE LINEAR REGRESSION ANALYSIS; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 79956344030     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2011.22075     Document Type: Article

References (25)

1. Wu CJ, Chang HW, Hung WC, et al. N-terminal pro-brain natriuretic peptide is a biomarker of congestive heart failure and predictive of 30-day untoward clinical outcomes in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Circ J 2006; 70: 163-8.
2. Wang TJ, Larson MG, Levy D, et al. The impact of obesity on plasma natriuretic peptide levels: the Framingham Heart Study. Circulation 2004; 109: 594-600. (Pubitemid 38198866)
3. Das SR, Drazner MH, Dries DL, et al. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 2005; 112: 2163-8. (Pubitemid 41475811)
4. Kanda H, Kita Y, Okamura T, et al. What factors are associated with high plasma B-type natriuretic peptide levels in a general Japanese population? J Hum Hypertens 2005; 19: 165-72.
5. Yano Y, Katsuki A, Gabazza EC, et al. Plasma brain natriuretic peptide levels in normotensive noninsulindependent diabetic patients with microalbuminuria. J Clin Endocrinol Metab 1999; 84: 2353-6.
6. Olsen MH, Hansen TW, Christensen MK, et al. N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension 2005; 46: 660-6. (Pubitemid 43186736)
7. Ceyhan C, Unal S, Yenisey C, Tekten T, Ceyhan FB. The role of N terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction: correlation with echocardiographic indexes in hyper - tensive patients. Int J Cardiovasc Imaging 2008; 24: 253-9.
8. Talwar S, Siebenhofer A, Williams B, Ng L. Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N terminal proBNP. Heart 2000; 83: 278-82. (Pubitemid 30313329)
9. Ogawa A, Seino Y, Yamashita T, Ogata k, Takano T. Difference in elevation of N-terminal pro-BNP and conventional cardiac markers between patients with ST elevation vs non-ST elevation acute coronary syndrome. Circ J 2006; 70: 1372-8.
10. Irzmański R, Piechota M, Barylski M, et al. NT-proBNP in patients after acute coronary syndrome with ST segment elevation subjected to early posthospitalization cardiologic rehabilitation. Arch Med Sci 2006; 4: 262-7. (Pubitemid 46121668)
11. Baghdady Y, Kamel Y, Elwan A. N-Terminal pro-Brain natriuretic peptide in decompansated ventricular septal defect. Arch Med Sci 2008; 3: 376-82.
12. Lafontan M, Moro C, Sengenes C, Galitzky J, Crampes F, Berlan M. An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in humans. Arterioscler Thromb Vasc Biol 2005; 25: 2032-42. (Pubitemid 41416298)
13. Mehra MR, Uber PA, Park MH, et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 2004; 43: 1590-5. (Pubitemid 38561338)
14. Messerli FH, Ventura HO, Reisin E, Dreslinski GR, Dunn FG, MacPhee AA. Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation 1982; 66: 55-60. (Pubitemid 12069957)
15. Hall C. Essential biochemistry and physiology of (NT-pro) BNP. Eur J Heart Fail 2004; 6: 257-60. (Pubitemid 38253043)
16. Moro C, Polak J, Richterova B, et al. Differential regulation of atrial natriuretic peptide- and adrenergic receptordependent lipolytic pathways in human adipose tissue. Metabolism 2005; 54: 122-31. (Pubitemid 39572467)
17. Kistorp C, Faber J, Galatius S, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005; 112: 1756-62. (Pubitemid 41372115)
18. Birkenfeld AL, Boschmann M, Moro C, et al. Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans. J Clin Endocrinol Metab 2005; 90: 3622-8. (Pubitemid 41014335)
19. Johnston CI, Hodsman PG, Kohzuki M, Casley DJ, Fabris B, Phillips PA. Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system: endogenous antagonists. Am J Med 1989; 87: 24S-8S.
20. Prasad A, Quyyumi AA. Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome. Circulation 2004; 110: 1507-12. (Pubitemid 39238031)
21. Buckley MG, Markandu ND, Miller MA, Sagnella GA, MacGregor GA. Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. J Hum Hypertens 1993; 7: 245-50. (Pubitemid 23194225)
22. Hanley AJ, Festa A, D'Agostino RB Jr, et al. Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. Diabetes 2004; 53: 1773-81. (Pubitemid 38857035)
23. Galasko GI, Lahiri A, Barnes SC, Collinson P, Senior R. What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease? Eur Heart J 2005; 26: 2269-76.
24. Wang TJ, Larson MG, Levy D, et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 2002; 90: 254-8. (Pubitemid 34804560)
25. Krauser DG, Lloyd-Jones DM, Chae CU, et al. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Am Heart J 2005; 149: 744-50.